JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5176
PUT
Talphera
TLPH
$59.7M
| $28K | ﹤0.01% |
670
-605
| -47% | -$36.3K |
2019 Q1
1 quarter
|
|
5177
Astrana Health
ASTH
$1.78B
| $28K | ﹤0.01% |
1,733
+922
| +114% | +$16.7K |
2018 Q2
4 quarters
|
|
|
LOGC
5178
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $28K | ﹤0.01% |
2,296
+314
| +16% | +$4.17K |
2018 Q4
2 quarters
|
|
|
TRMT
5179
DELISTED
Tremont Mortgage Trust Common Shares of Beneficial Interest
TRMT
| $28K | ﹤0.01% |
+6,900
| New | +$48.9K |
2019 Q2
0 quarters
|
|
5180
Celsius Holdings
CELH
$6.77B
| $27K | ﹤0.01% |
20,709
+3,990
| +24% | +$5.46K |
2018 Q2
4 quarters
|
|
5181
iShares MSCI Emerging Markets ex China ETF
EMXC
$26.4B
| $27K | ﹤0.01% |
550
| – | – |
2018 Q1
5 quarters
|
|
5182
Greene County Bancorp
GCBC
$583M
| $27K | ﹤0.01% |
1,818
-194
| -10% | -$2.91K |
2017 Q4
6 quarters
|
|
|
LRFC
5183
DELISTED
Logan Ridge Finance Corp
LRFC
| $27K | ﹤0.01% |
+481
| New | +$25.5K |
2019 Q2
0 quarters
|
|
5184
Mustang Bio
MBIO
$3.49M
| $27K | ﹤0.01% |
10
+5
| +100% | +$14.3K |
2018 Q2
4 quarters
|
|
5185
Savara
SVRA
$986M
| $27K | ﹤0.01% |
11,335
-46,232
| -80% | -$411K |
2018 Q1
5 quarters
|
|
|
SBOW
5186
DELISTED
SilverBow Resources, Inc.
SBOW
| $27K | ﹤0.01% |
1,944
+215
| +12% | +$3.64K |
2018 Q3
3 quarters
|
|
|
NGM
5187
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $27K | ﹤0.01% |
+1,847
| New | +$27K |
2019 Q2
0 quarters
|
|
|
VAPO
5188
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $27K | ﹤0.01% |
160
+16
| +11% | +$2.37K |
2018 Q4
2 quarters
|
|
|
USWS
5189
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
| $27K | ﹤0.01% |
263
-289
| -52% | -$42.8K |
2019 Q1
1 quarter
|
|
|
CHKR
5190
DELISTED
CHESAPEAKE GRANITE WASH TRUST
CHKR
| $27K | ﹤0.01% |
25,600
+5,500
| +27% | +$7.11K |
2016 Q2
12 quarters
|
|
5191
Capital Bancorp
CBNK
$659M
| $26K | ﹤0.01% |
2,185
+632
| +41% | +$7.44K |
2018 Q4
2 quarters
|
|
5192
First Guaranty Bancshares
FGBI
$138M
| $26K | ﹤0.01% |
1,557
+135
| +9% | +$2.35K |
2017 Q4
6 quarters
|
|
5193
Kamada
KMDA
$468M
| $26K | ﹤0.01% |
+4,796
| New | +$27.4K |
2019 Q2
0 quarters
|
|
5194
Invesco Water Resources ETF
PHO
$1.89B
| $26K | ﹤0.01% |
728
| – | – |
2017 Q4
6 quarters
|
|
5195
Invesco Global Listed Private Equity ETF
PSP
$210M
| $26K | ﹤0.01% |
436
-80
| -16% | -$4.73K |
2018 Q3
3 quarters
|
|
5196
ProShares Ultra Health Care
RXL
$92M
| $26K | ﹤0.01% |
+1,016
| New | +$25.2K |
2019 Q2
0 quarters
|
|
|
THOR
5197
DELISTED
Synthorx, Inc. Common Stock
THOR
| $26K | ﹤0.01% |
2,015
-17,482
| -90% | -$280K |
2019 Q1
1 quarter
|
|
5198
Kopin
KOPN
$905M
| $25K | ﹤0.01% |
21,771
+7,355
| +51% | +$8.94K |
2017 Q4
6 quarters
|
|
5199
Mayville Engineering Co
MEC
$415M
| $25K | ﹤0.01% |
+1,732
| New | +$26.7K |
2019 Q2
0 quarters
|
|
5200
Fidelity Nasdaq Composite Index ETF
ONEQ
$11.1B
| $25K | ﹤0.01% |
800
| – | – |
2019 Q1
1 quarter
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.